Biopsy information and protein Prostate-Specific Antigen (PSA) levels are the most robust information available to oncologists worldwide to diagnose and decide therapies for prostate cancer patients. However, prostate cancer presents a high risk of recurrence, and the technologies used to evaluate it demand more complex resources. This paper aims to predict Biochemical Recurrence (BCR) based on Whole Slide Images (WSI) of biopsies, Gleason scores, and PSA levels.

DOI Link: 
10.21227/1g5n-vd67
Read more

Dataset Files

You must be an IEEE Dataport Subscriber to access these files. Subscribe now or login.

[1] Laura Marin, Fanny Casado, "Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information", IEEE Dataport, 2024. [Online]. Available: http://dx.doi.org/10.21227/1g5n-vd67. Accessed: Dec. 08, 2024.
@data{1g5n-vd67-24,
doi = {10.21227/1g5n-vd67},
url = {http://dx.doi.org/10.21227/1g5n-vd67},
author = {Laura Marin; Fanny Casado },
publisher = {IEEE Dataport},
title = {Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information},
year = {2024} }
TY - DATA
T1 - Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information
AU - Laura Marin; Fanny Casado
PY - 2024
PB - IEEE Dataport
UR - 10.21227/1g5n-vd67
ER -
Laura Marin, Fanny Casado. (2024). Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information. IEEE Dataport. http://dx.doi.org/10.21227/1g5n-vd67
Laura Marin, Fanny Casado, 2024. Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information. Available at: http://dx.doi.org/10.21227/1g5n-vd67.
Laura Marin, Fanny Casado. (2024). "Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information." Web.
1. Laura Marin, Fanny Casado. Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information [Internet]. IEEE Dataport; 2024. Available from : http://dx.doi.org/10.21227/1g5n-vd67
Laura Marin, Fanny Casado. "Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information." doi: 10.21227/1g5n-vd67